Johnson & Johnson (JNJ) Receivables (2009 - 2026)
Johnson & Johnson's Receivables was $19.05 billion in Q2 2026, up 6.7% from $17.85 billion a year earlier and up 7.5% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Johnson & Johnson came in at $17.18 billion, up 15.7% from FY2024.
- Receivables shows a four-year compound annual growth rate of 6.1% (FY2021 to FY2025).
- In earlier years, Receivables was $14.84 billion in FY2024 (-0.2%), $14.87 billion in FY2023 (+5.9%), $14.04 billion in FY2022 and $13.58 billion in FY2021.
- The Q2 2026 figure marks the highest quarterly Receivables in data going back to Q4 2011.
- Compared with a year earlier, Receivables has increased for six straight quarters, with growth averaging 8.9% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2025 (growth of 15.7%); the worst was Q1 2024 (a decline of 8.6%).
- Per Business Quant data, JNJ's Receivables in the three quarters before Q2 2026 was $17.72 billion (Q1 2026), $17.18 billion (Q4 2025) and $17.61 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 19.05 Bn |
| Mar 29, 2026 | 17.72 Bn |
| Dec 28, 2025 | 17.18 Bn |
| Sep 28, 2025 | 17.61 Bn |
| Jun 29, 2025 | 17.85 Bn |
| Mar 30, 2025 | 16.02 Bn |
| Dec 29, 2024 | 14.84 Bn |
| Sep 29, 2024 | 16.17 Bn |
| Jun 30, 2024 | 15.79 Bn |
| Mar 31, 2024 | 14.95 Bn |
| Dec 31, 2023 | 14.87 Bn |
| Oct 1, 2023 | 14.80 Bn |
| Jul 2, 2023 | 16.78 Bn |
| Apr 2, 2023 | 16.35 Bn |
| Jan 1, 2023 | 14.04 Bn |
| Oct 2, 2022 | 15.89 Bn |
| Jul 3, 2022 | 16.14 Bn |
| Apr 3, 2022 | 15.59 Bn |
| Jan 2, 2022 | 15.28 Bn |
| Oct 3, 2021 | 14.91 Bn |
API Access
Johnson & Johnson Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();